Molecular and phenotypic expression of decorin as modulator of angiogenesis in human potentially malignant oral lesions and oral squamous cell carcinomas

Indian Journal of Pathology and Microbiology

Volumn 56, Issue 3, 2013, Pages 204-210

  Nayak, Seema ^c   Goel, Madhu Mati ^c   Bhatia, Vikram ^c   Chandra, Saumya ^c   Makker, Annu ^c   Kumar, Sandeep ^a   Agrawal, Satya Prakash ^b   Mehrotra, Divya ^c   Rath, Srikanta Kumar ^d  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Department of Otolaryngology ^*  (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Angiogenesis; Decorin; Potentially malignant oral lesions; Squamous cell carcinoma; Vascular endothelial growth factor A

Indexed keywords

CD31 ANTIGEN; DECORIN; MESSENGER RNA; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM; FEMALE; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MOUTH DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; STAINING; STROMA; TUMOR BIOPSY;

ADULT; BIOPSY; CARCINOMA, SQUAMOUS CELL; DECORIN; FEMALE; FIBROSIS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888378279     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.120366     Document Type: Article

References (29)

1. Byakodi R, Byakodi S, Hiremath S, Byakodi J, Adaki S, Marathe K, et al. Oral cancer in India: An epidemiologic and clinical review. J Community Health 2012;37:316-9.
2. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999;274:18843-6.
3. Schönherr E, Sunderkötter C, Iozzo RV, Schaefer L. Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 2005;280:15767-72.
4. Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21 (WAF1/CIP1) but not p27(KIP1). J Biol Chem 2001;276:40687-92.
5. Davies Cde L, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y. Decorin inhibits endothelial migration and tube-like structure formation: Role of thrombospondin-1. Microvasc Res 2001;62:26-42.
6. Iozzo RV, Cohen I. Altered proteoglycan gene expression and the tumor stroma. Experientia 1993;49:447-55.
7. McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002;8:1127-38.
8. Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, et al. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 2003;9:207-14.
9. Rykova VI, Grigorieva EV, Chernenko AV, Eshenko TY, Dymshits GM. Proteoglycans and human breast cancer. Bull Exp Biol Med 2007;144:335-7.
10. Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, et al. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells 2002;14:382-7.
11. Grisaru D, Hauspy J, Prasad M, Albert M, Murphy KJ, Covens A, et al. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings. Oncol Rep 2007;18:1347-56.
12. Stylianou M, Skandalis SS, Papadas TA, Mastronikolis NS, Theocharis DA, Papageorgakopoulou N, et al. Stage-related decorin and versican expression in human laryngeal cancer. Anticancer Res 2008;28:245-51.
13. Skandalis SS, Theocharis AD, Papageorgakopoulou N, Vynios DH, Theocharis DA. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie 2006;88:1135-43.
14. Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res 2003;63:7769-76.
15. Shang ZJ, Li JR. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: Its correlation with angiogenesis and disease progression. J Oral Pathol Med 2005;34:134-9.
16. Bancroft CC, Chen Z, Dong G, Sunwoo JB, Yeh N, Park C, et al. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res 2001;7:435-42.
17. Nayak S, Goel MM, Chandra S, Bhatia V, Mehrotra D, Kumar S, et al. VEGF-A immunohistochemical and mRNA expression in tissues and its serum levels in potentially malignant oral lesions and oral squamous cell carcinomas. Oral Oncol 2012;48:233-9.
18. Karavasilis V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, et al. Angiogenesis in cancer of unknown primary: Clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer 2005;5:25.
19. Guttman D, Stern Y, Shpitzer T, Ulanovski D, Druzd T, Feinmesser R. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 2004;40:798-803.
20. Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005;18:143-52.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
22. Schönherr E, Sunderkötter C, Schaefer L, Thanos S, Grässel S, Oldberg A, et al. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 2004;41:499-508.
23. Nelimarkka L, Salminen H, Kuopio T, Nikkari S, Ekfors T, Laine J, et al. Decorin is produced by capillary endothelial cells in inflammationassociated angiogenesis. Am J Pathol 2001;158:345-53.
24. Goldoni S, Iozzo RV. Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 2008;123:2473-9.
25. Adany R, Iozzo RV. Hypomethylation of the decorin proteoglycan gene in human colon cancer. Biochem J 1991;276 (Pt 2):301-6.
26. Dil N, Banerjee AG. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Head Neck Oncol 2011;3:44.
27. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002;21:4765-77.
28. Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, et al. Neck dissection field and ly mph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol 2012;48:329-36.
29. Newton TR, Parsons PG, Lincoln DJ, Cummings MC, Wyld DK, Webb PM, et al. Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer. Int J Cancer 2006;119:875-83.